Baseline characteristics
| DES 276 (42%) | BMS 376 (58%) | p Value | |
| Demographic data | |||
| Age (years) | 66 (54–74) | 72 (60–78) | <0.001 |
| Female gender | 28 (63/276) | 34 (128/376) | 0.002 |
| Body mass index (kg/m²) | 27 (25–30) | 27 (25–30) | 0.89 |
| Cardiovascular risk factors | |||
| Arterial hypertension | 6 (181/274) | 67 (250/371) | 0.72 |
| Dyslipidaemia | 45 (122/273) | 29 (106/371) | <0.001 |
| Diabetes mellitus | 29 (79/274) | 36 (133/372) | 0.06 |
| Current smoker | 39 (106/273) | 32 (117/370) | 0.06 |
| Peripheral arterial disease | 12 (32/276) | 13 (48/374) | 0.63 |
| Prior myocardial infarction | 20 (54/276) | 9 (72/374) | 0.92 |
| Prior stroke | 7 (19/276) | 7 (25/374) | 0.92 |
| ECG on admission | |||
| ST-segment elevation myocardial infarction | 74 (201/271) | 80 (294/368) | 0.11 |
| Anterior myocardial infarction | 50 (135/272) | 38 (140/368) | 0.003 |
| Atrial fibrillation | 8 (22/276) | 16 (59/376) | 0.003 |
| Clinical course before PCI | |||
| Fibrinolysis therapy ≤24 hours | 7 (19/276) | 9 (33/376) | 0.38 |
| Resuscitation | 48 (131/276) | 45 (169/376) | 0.52 |
| Mechanical ventilation at admission | 52 (144/276) | 58 (218/376) | 0.14 |
| Mean arterial pressure (mm Hg) | 72 (62–85) | 67 (57–80) | <0.001 |
| Laboratory results | |||
| Serum lactate (mmol/L) | 3.4 (1.8–7.0) | 3.9 (2.2–7.6) | 0.05 |
| Creatine kinase (µkat/L) | 5.6 (2.6–18.9) | 7.0 (3.0–20.2) | 0.14 |
| Serum creatine (µmol/L) | 106 (88–141) | 119 (97–154) | 0.007 |
| C reactive protein (mg/L) | 6.8 (2.0–29.0) | 8.7 (3.4–47.6) | 0.05 |
| International normalised ratio | 1.1 (1.0–1.4) | 1.2 (1.1–1.5) | 0.002 |
| Haemoglobine (mmol/L) | 8.4 (7.6–9.1) | 8.1 (6.9–9.0) | 0.002 |
| Leucocytes (109/L) | 14.0 (10.5–18.1) | 14.2 (10.7–18.5) | 0.96 |
| Blood glucose (mmol/L) | 11.6 (8.1–16.7) | 11.5 (8.0–17.2) | 0.66 |
Values are % (n/N) or median and IQR.
BMS, bare-mental stent; DES, drug-eluting stent; PCI, percutaneous coronary intervention.